The number of people with susceptibility test result for rifampicin in South Sudan

South Sudan: The number of people with susceptibility test result for rifampicin was 0 in 2021. ◆ Volatile

Latest (2021)
0
Change on year
down 100.0%
World rank
146th
of 155 countries
All-time high
329
in 2020
All-time low
0
in 2021
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in South Sudan, 2017–2021

01002003002017201920212017: 1792018: 422019: 122020: 3292021: 0

Source: World Health Organization, Global Health Observatory.

Analysis

South Sudan recorded 0 for the number of people with susceptibility test result for rifampicin in 2021. That is the lowest value across all 5 years on record.

Compared with earlier readings it is down 100.0% on the previous year and down 100.0% over five years.

South Sudan ranks 146th of 155 countries on this measure, in the bottom quarter.

The number of people with susceptibility test result for rifampicin in South Sudan, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. in South Sudan, 2017 to 2021.
Year Value Change
2017 179
2018 42 -76.5%
2019 12 -71.4%
2020 329 +2641.7%
2021 0 -100.0%

South Sudan compared with similar countries

  • South Sudan's 0 is below the median for low income countries, which is 1,934. (15 countries reporting)
  • South Sudan's 0 is below the median for Sub-Saharan Africa, which is 2,015. (33 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 77.67 12 179 3
2020s 164.5 0 329 2

Countries ranked near South Sudan

  1. 143 Saint Lucia 2 compare
  2. 143 Bermuda 2 compare
  3. 143 Andorra 2 compare
  4. 146 Grenada 0 compare
  5. 146 Niue 0
  6. 146 Mauritania 0 compare
  7. 146 Barbados 0 compare
  8. 146 Saint Kitts and Nevis 0 compare
  9. 146 Sao Tome and Principe 0 compare
  10. 146 Vanuatu 0 compare
  11. 146 Antigua and Barbuda 0
  12. 146 Saint Vincent and the Grenadines 0 compare

See the full ranking of 157 places →

More health data for South Sudan

All data for South Sudan →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in South Sudan?
The number of people with susceptibility test result for rifampicin in South Sudan was 0 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in South Sudan?
The highest recorded value was 329 in 2020.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in South Sudan?
The lowest recorded value was 0 in 2021.
How does South Sudan rank for the number of people with susceptibility test result for rifampicin?
South Sudan ranks 146th out of 155 countries with data for 2021.
Where does this South Sudan data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in South Sudan. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 16 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/south-sudan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/south-sudan/">The number of people with susceptibility test result for rifampicin in South Sudan</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed